Gabelova A - Search Results

1

Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives.

Buocikova V, Rios-Mondragon I, Pilalis E, Chatziioannou A, Miklikova S, Mego M, Pajuste K, Rucins M, Yamani NE, Longhin EM, Sobolev A, Freixanet M, Puntes V, Plotniece A, Dusinska M, Cimpan MR, Gabelova A, Smolkova B. Buocikova V, et al. Among authors: gabelova a. Cancers (Basel). 2020 Dec 3;12(12):3622. doi: 10.3390/cancers12123622. Cancers (Basel). 2020. PMID: 33287297 Free PMC article. Review.

2

An evaluation of three pesticides: piritione, supercypermethrin and metolachlor in transformation bioassays of BHK21 and hamster embryo cells.

Slamenová D, Dusinská M, Gábelová A, Bohusová T, Oravec C. Slamenová D, et al. Among authors: gabelova a. Cell Biol Toxicol. 1992 Oct-Dec;8(4):217-31. doi: 10.1007/BF00156732. Cell Biol Toxicol. 1992. PMID: 1493583

3

Decemtione (Imidan)-induced single-strand breaks to human DNA, mutations at the hgprt locus of V79 cells, and morphological transformations of embryo cells.

Slamenová D, Dusinská M, Gábelová A, Bohusová T, Ruppová K. Slamenová D, et al. Among authors: gabelova a. Environ Mol Mutagen. 1992;20(1):73-8. doi: 10.1002/em.2850200111. Environ Mol Mutagen. 1992. PMID: 1639085

4

Differences between survival, mutagenicity and DNA replication in MMS- and MNU-treated V79 hamster cells.

Slamenová D, Dusinská M, Bastlová T, Gábelová A. Slamenová D, et al. Among authors: gabelova a. Mutat Res. 1990 Jan;228(1):97-103. doi: 10.1016/0027-5107(90)90017-x. Mutat Res. 1990. PMID: 2300062

5

Assessment of toxicity, clastogenicity, mutagenicity and transforming activity of pentoxifylline in mammalian cells cultured in vitro.

Slamenová D, Dusinská M, Gábelová A, Horváthová E, Oravec C, Chalupa I, Szabová E. Slamenová D, et al. Among authors: gabelova a. Mutat Res. 1994 Oct;322(4):275-85. doi: 10.1016/0165-1218(94)90103-1. Mutat Res. 1994. PMID: 7523921

6

Role of cytoplasmic membrane in the screening of potential tumour promoters.

Gábelová A, Dusinská M, Slamenová D. Gábelová A, et al. Cancer Lett. 1995 Aug 16;95(1-2):63-7. doi: 10.1016/0304-3835(95)03861-p. Cancer Lett. 1995. PMID: 7656245

7

DNA-synthesis inhibition and repair DNA-synthesis in CHO Ade-C cells: an alternative approach to genotoxicity testing.

Slamenová D, Collins A, Wsólová L, Papsová E, Gábelová A, Dusinská M. Slamenová D, et al. Among authors: gabelova a. Neoplasma. 1997;44(4):247-52. Neoplasma. 1997. PMID: 9473778

8

Nanomedicine and epigenome. Possible health risks.

Smolkova B, Dusinska M, Gabelova A. Smolkova B, et al. Among authors: gabelova a. Food Chem Toxicol. 2017 Nov;109(Pt 1):780-796. doi: 10.1016/j.fct.2017.07.020. Epub 2017 Jul 11. Food Chem Toxicol. 2017. PMID: 28705729 Free article. Review.

9

Microfluidic In Vitro Platform for (Nano)Safety and (Nano)Drug Efficiency Screening.

Kohl Y, Biehl M, Spring S, Hesler M, Ogourtsov V, Todorovic M, Owen J, Elje E, Kopecka K, Moriones OH, Bastús NG, Simon P, Dubaj T, Rundén-Pran E, Puntes V, William N, von Briesen H, Wagner S, Kapur N, Mariussen E, Nelson A, Gabelova A, Dusinska M, Velten T, Knoll T. Kohl Y, et al. Among authors: gabelova a. Small. 2021 Apr;17(15):e2006012. doi: 10.1002/smll.202006012. Epub 2021 Jan 18. Small. 2021. PMID: 33458959 Free article.

10

Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure.

Soltysova A, Begerova P, Jakic K, Kozics K, Sramkova M, Meese E, Smolkova B, Gabelova A. Soltysova A, et al. Among authors: gabelova a. Cell Biol Toxicol. 2023 Oct;39(5):1939-1956. doi: 10.1007/s10565-021-09680-3. Epub 2022 Jan 1. Cell Biol Toxicol. 2023. PMID: 34973136 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page